Wen Song Tan
Directeur/Bestuurslid bij Tasly Biopharmaceuticals Co., Ltd.
Profiel
Wen Song Tan is an Independent Non-Executive Director at Tasly Biopharmaceuticals Co., Ltd.
and VP-Cell Engineering & Transgenic Organism Branch at Chinese Society For Cell Biology.
He was the Director-Higher Education at East China University of Science & Technology from 2009 to 2015 and a Member-Tissue Engineering & Regenerative Medicine at Chinese Society of Biomedical Engineering from 2013 to 2017.
Dr. Tan earned his doctorate degree from East China University of Science & Technology in 1993.
Actieve functies van Wen Song Tan
Bedrijven | Functie | Begin |
---|---|---|
Tasly Biopharmaceuticals Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 15-04-2019 |
Chinese Society For Cell Biology | Corporate Officer/Principal | 01-10-2016 |
Eerdere bekende functies van Wen Song Tan
Bedrijven | Functie | Einde |
---|---|---|
Chinese Society of Biomedical Engineering | Corporate Officer/Principal | 01-04-2017 |
East China University of Science & Technology | Corporate Officer/Principal | 01-12-2015 |
Opleiding van Wen Song Tan
East China University of Science & Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Tasly Biopharmaceuticals Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Health Technology |
Chinese Society For Cell Biology | |
Chinese Society of Biomedical Engineering |